Form 4 for RMD ResMed|
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001127602-21-029539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-18 | 2021-11-16+ | RMD | PENDARVIS DAVID | Chief Administrative Off | A - Grant | $241.08 | +18.3K | 119.1K | +18% | +$4.41M |
| 2021-11-18 | 2021-11-17 | RMD | PENDARVIS DAVID | Chief Administrative Off | F - Tax | $254.81 | -9,655 | 118.1K | -8% | -$2.46M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-11-16 | A | A | 17,307 | $254.81 | 127,792 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2021-11-18 | A | A | 986 | $0.00 | 119,123 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2021-11-17 | F | D | 9,655 | $254.81 | 118,137 | D | — | — |